Dental News - AlloSorb Allograft by RIEMSER

Search Dental Tribune

AlloSorb Allograft by RIEMSER

AlloSorb Allograft by RIEMSER (DTI/Photo RIEMSER)
RIEMSER

RIEMSER

Tue. 8 June 2010

save

RIEMSER, a leader in oral surgery technology, recently announced the launch of AlloSorb, a cost-competitive allograft that provides a natural structure and framework to build healthy bone in the regeneration process. AlloSorb is a STERILE-R allograft certified by the American Association of Tissue Banks (AATB). AlloSorb utilizes the latest and most innovative sterilization and processing method, Allowash.

Allowash is a patented technology that minimizes the risk of disease transmission by facilitating the removal of cellular elements from musculoskeletal tissue, without degrading the tissues’ structural integrity. AlloSorb is low-dose irradiated.

Furthermore, to achieve the highest possible patient safety, the AlloSorb screening process for donors meets or exceeds FDA regulations and AATB standards.

AlloSorb is available in three types of particulate: mineralized cancellous, demineralized cortical and mineralized cortical, in .5 cc, 1.0 cc and 2.0 cc vials. It will soon be available in block form.

“Our customers include oral surgeons, periodontists and other implantologists who want RIEMSER to serve as a one-stop supplier for all their bone grafting needs, which is why we are pleased to add this safe, cost-competitive allograft product to our growing line,” said Director of National Sales Vince Ellero.

More information is available from RIEMSER.

To post a reply please login or register
advertisement
advertisement